Bold
Investors
ASX
Latest News
ASX Announcements
Companies
Home
ASX Announcements
AGN Announcements
ARG007 Shows Significant…
AGN
ARGENICA THERAPEUTICS LIMITED
Market sensitive
ARG007 Shows Significant Neuroprotection in Concussion Study
Date and time
16 July 2026 at 6:27 pm
Announcement type
Company Update
Show details
Hide details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASX
Open original PDF
AGN announcement history
Recent AGN announcements
Notification of cessation of securities - AGN
Investor Presentation - Techknow Conference
Quarterly Activities/Appendix 4C Cash Flow Report
Investor Webinar
Investor Presentation
ARG007 (Xaranetide) Completes All Three FDA Requested Assays